AstraZeneca Pharma India Q1 Results, Net Loss of ₹110.5 Million and Total Income of ₹3,958.7 Million

AstraZeneca Pharma India Q1 Results: AstraZeneca Pharma India declared its Q1 results for the financial year 2024-2025 on August 8, 2024, showing a 1.02% quarter-on-quarter (QoQ) increase in total expenses. Total expenses for the quarter ending June 2024 rose to ₹3,534.7 million, compared to ₹3,375.0 million in the March 2024 quarter.

Despite the increase in expenses, the company's revenue from operations showed only a 1.12% QoQ increase, reaching ₹3,875.2 million. This rise in total expenses was driven primarily by a significant 220.6% QoQ increase in purchases of stock-in-trade, which surged to ₹2,403.3 million from ₹749.8 million in the previous quarter.

Employee benefit expenses also grew by 5.1% QoQ, contributing to the overall rise in costs. The increase in expenses outpaced the growth in revenue, leading to a net loss of ₹110.5 million for the quarter, compared to a profit of ₹396.8 million in Q4 of the previous fiscal year.

For More Q1 results check our Twitter Page

AstraZeneca Pharma India Q1 Results 2024 - 2025

AstraZeneca Pharma India announced its Q1 results for the financial year 2024-2025 on August 8, 2024. The results show a slight increase in revenue but a significant rise in expenses, leading to a net loss for the quarter. Below is a summary of the key financial metrics from Q1 compared to the previous quarter:

Source: Click Here

AstraZeneca Pharma India Current Market Overview

Here is a table summarizing the current market overview of AstraZeneca Pharma India:

Quarterly Results

Here is a summary of AstraZeneca Pharma India's quarterly results for the recent periods. The table below includes key financial metrics such as sales, expenses, operating profit, and net profit for December 2023, March 2024, and June 2024:

AstraZeneca Pharma India 

AstraZeneca Pharma India, established in 1979, is a leading pharmaceutical company based in Bengaluru, Karnataka. It is a subsidiary of AstraZeneca Plc, UK, and focuses on manufacturing, sales, and marketing of medicines in India.

The company is science-driven and committed to improving healthcare by developing innovative treatments for various medical conditions. AstraZeneca Pharma India is known for its work in areas such as oncology, cardiovascular health, and respiratory diseases, aiming to make a positive impact on patients' lives and healthcare across the country.

Check our website for more Q1 results.